Page last updated: 2024-08-21

d-alpha tocopherol and epalrestat

d-alpha tocopherol has been researched along with epalrestat in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barresi, E; Cosconati, S; Da Settimo, F; Di Maro, S; La Motta, C; Marinelli, L; Marini, AM; Novellino, E; Salerno, S; Sartini, S; Simorini, F; Taliani, S	1
Azuma, K; Fujitani, Y; Hirose, T; Ikeda, F; Kanazawa, A; Kawamori, R; Ohmura, C; Shimizu, T; Tanaka, Y; Watada, H; Yoshihara, T	1
Banala, VT; Dwivedi, M; Gautam, S; Marwaha, D; Mishra, PR; Sharma, M; Sharma, S; Shukla, RP; Urandur, S	1

Trials

1 trial(s) available for d-alpha tocopherol and epalrestat

Article	Year
Aldose reductase inhibitor, epalrestat, reduces lipid hydroperoxides in type 2 diabetes. Endocrine journal, 2009, Volume: 56, Issue:1 Topics: Adult; Aged; Aldehyde Reductase; beta Carotene; Diabetes Mellitus, Type 2; Down-Regulation; Enzyme Inhibitors; Erythrocytes; Female; Humans; Lipid Peroxidation; Lipid Peroxides; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Rhodanine; Thiazolidines; Thiobarbituric Acid Reactive Substances; Vitamin E	2009

Article

Year

Aldose reductase inhibitor, epalrestat, reduces lipid hydroperoxides in type 2 diabetes.

Endocrine journal, 2009, Volume: 56, Issue:1

Topics: Adult; Aged; Aldehyde Reductase; beta Carotene; Diabetes Mellitus, Type 2; Down-Regulation; Enzyme Inhibitors; Erythrocytes; Female; Humans; Lipid Peroxidation; Lipid Peroxides; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Rhodanine; Thiazolidines; Thiobarbituric Acid Reactive Substances; Vitamin E

2009

Other Studies

2 other study(ies) available for d-alpha tocopherol and epalrestat

Article	Year
Benzofuroxane derivatives as multi-effective agents for the treatment of cardiovascular diabetic complications. Synthesis, functional evaluation, and molecular modeling studies. Journal of medicinal chemistry, 2012, Dec-13, Volume: 55, Issue:23 Topics: Animals; Benzoxazoles; Cardiovascular Diseases; Diabetes Complications; Humans; Liver; Models, Molecular; Molecular Docking Simulation; Rats	2012
Targeted co-delivery of the aldose reductase inhibitor epalrestat and chemotherapeutic doxorubicin via a redox-sensitive prodrug approach promotes synergistic tumor suppression. Biomaterials science, 2019, Jun-25, Volume: 7, Issue:7 Topics: Aldehyde Reductase; Animals; Antineoplastic Agents; Doxorubicin; Drug Carriers; Drug Liberation; Drug Synergism; Enzyme Inhibitors; Female; Humans; Intracellular Space; Mice; Micelles; Oxidation-Reduction; Prodrugs; Rhodanine; Thiazolidines; Tissue Distribution; Vitamin B 6; Vitamin E	2019

Article

Year

Benzofuroxane derivatives as multi-effective agents for the treatment of cardiovascular diabetic complications. Synthesis, functional evaluation, and molecular modeling studies.

Journal of medicinal chemistry, 2012, Dec-13, Volume: 55, Issue:23

Topics: Animals; Benzoxazoles; Cardiovascular Diseases; Diabetes Complications; Humans; Liver; Models, Molecular; Molecular Docking Simulation; Rats

2012

Targeted co-delivery of the aldose reductase inhibitor epalrestat and chemotherapeutic doxorubicin via a redox-sensitive prodrug approach promotes synergistic tumor suppression.

Biomaterials science, 2019, Jun-25, Volume: 7, Issue:7

Topics: Aldehyde Reductase; Animals; Antineoplastic Agents; Doxorubicin; Drug Carriers; Drug Liberation; Drug Synergism; Enzyme Inhibitors; Female; Humans; Intracellular Space; Mice; Micelles; Oxidation-Reduction; Prodrugs; Rhodanine; Thiazolidines; Tissue Distribution; Vitamin B 6; Vitamin E

2019